SCHEMBL8805278

SCHEMBL8805278

Cc1nc2sccn2c(=O)c1CCN1CC2CC(c3ccc[nH]3)C2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 6/20 0.47
▸ MAPT P10636 4/20 0.47
▸ HTR1A P08908 4/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ TDP1 Q9NUW8 3/20 0.47
▸ CYP2D6 P10635 3/20 0.47
▸ TSHR P16473 3/20 0.47
▸ DRD2 P14416 3/20 0.47
▸ HTR2A P28223 3/20 0.47
▸ HTR2C P28335 3/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ TP53 P04637 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ ALOX15 P16050 2/20 0.47
▸ DGKA P23743 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ ADRA1A P35348 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8805519 0.86 TDP1 (0.52) PKMMAPTHTR1ASMN1; SMN2TDP1
SCHEMBL8805082 0.84 PKM (0.48) PKMMAPTHTR1ASMN1; SMN2TDP1
SCHEMBL8803343 0.83 CYP2D6 (0.51) PKMMAPTHTR1ASMN1; SMN2TDP1
SCHEMBL8804592 0.83 PKM (0.47) PKMMAPTHTR1ASMN1; SMN2TDP1
SCHEMBL9136196 0.83 PKM (0.47) PKMMAPTHTR1ASMN1; SMN2TDP1
SCHEMBL8802868 0.83 PKM (0.58) PKMMAPTHTR1ASMN1; SMN2TDP1
SCHEMBL8804391 0.83 PKM (0.47) PKMMAPTHTR1ASMN1; SMN2TDP1
SCHEMBL8805781 0.83 MAPT (0.49) PKMMAPTHTR1ASMN1; SMN2TDP1
SCHEMBL8190364 0.83 TDP1 (0.47) PKMMAPTHTR1ASMN1; SMN2TDP1
SCHEMBL8805291 0.83 PKM (0.46) PKMMAPTHTR1ASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0647231-B1 N-SUBSTITUTED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS, ETC. BASF AG (DE) 1997-08-27 — — EP disclosed
US-5475105-A N-substituted azabicycloheptane derivatives BASF AKTIENGESELLSCHAFT (DE) 1995-12-12 — — US disclosed
Send feedback